MGMT and glioblastoma: In 2007, Mikeska et al. [11] optimized pyrosequencing (see Box A for methodological background) for testing of MGMT promoter methylation status in glioblastoma specimens and demonstrated feasibility and reliability in snap-frozen and formalin fixed paraffin-embedded specimens.